Nishtar Medical University and Hospital, Multan, Pakistan (Shah)
Provides sustained release
Will MACE reduction match surrogate markers
Such differences in compliance between GLP-1RA preparations are mainly due to the differences between injection devices [172]
The compound must not be supplied for or administered to humans outside of formally regulated clinical trial frameworks
Also, the growth strategies adopted by these players to compete in the fast-growing market Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions